The Duchenne muscular dystrophy (DMD) landscape across the seven major markets (7MM) - the US, France, Germany, Italy, Spain, ...

Regenerative Medicine Market Growth BURLINGAME, CA, UNITED STATES, February 14, 2025 /EINPresswire / --The global Regenerative Medicin ...

Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit ...

BAY RIDGE, Brooklyn (PIX11) — One person has died and two more were injured during a fatal fire in Bay Ridge early Sunday ...

Thieves took four cases of Girl Scout cookies while they were setting up in Alameda on Saturday. Even Stevens alum Christy ...

Hansa Biopharma reported its Q4 2024 earnings, revealing a larger-than-expected loss and lower-than-forecast revenue. The company posted an EPS of -4.08, significantly missing the forecast of -1.98, ...

The Moon is among 25 sites on the World Monuments Fund's 2025 Watch list, Goodwood Festival of Speed's plans to host ‘its biggest ever celebrations’ in honour of the 75th anniversary of the Formula 1 ...

In this article, we are going to take a look at where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands against the other stocks. Jim Cramer, the host of Mad Money, recently expressed his concerns ...

Shares of Sarepta (SRPT) are down this morning, potentially due to the latest FDA Adverse Event Reporting System update on Elevidys, which included a patient death from November in a patient who ...

Sarepta Therapeutics, Guangdong Raynovent, Lassen Therapeutics, Contineum Therapeutics, and others are evaluating new pulmonary fibrosis drugs to improve the treatment landscape. Promising ...

In a report released yesterday, Kostas Biliouris from BMO Capital maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), with a price target of $200.00. Kostas Biliouris has ...